Evaluation the safety and effectiveness of Oxiplex Gel for reduction of pain and associated symptoms followingsingle level lumbar discectomy

Phase 2

Recruiting

• Conditions: umbar disc.; Unspecified thoracic, thoracolumbar and lumbosacral intervertebral disc disorder; M51.9

• Registration Number: IRCT20141209020258N106
• Lead Sponsor: Arak University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 21 May 2019

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

18-70 years
Lumbar disc disease

Exclusion Criteria

Dissatisfaction

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Disability. Timepoint: Before intervention, 1, 3 and 6 months after intervention. Method of measurement: Oswestry low back pain disability.;Pain. Timepoint: Before intervention, 1, 3 and 6 months after intervention. Method of measurement: Visual analog scale.